Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Studies on solution conformations and mechanism of action of amrinone and milrinone

Conference · · Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States)
OSTI ID:6991704
There are two structural differences between the positive inotropes amrinone (A) and milrinone (M): (1) M has a pyridone 2-methyl substituent and; (2) the pyridone 5-amino substituent of A is replaced with a nitrile in M. SAR studies confirmed that the 2-methyl substituent is responsible for the dramatically increased potency of M relative to A (canine i.v. ED/sub 50/'s=37 and 1891 ..mu..g/kg, respectively). Both M and A inhibited canine heart PDEase III (IC/sub 50/'s=12 and 150..mu..M, respectively). Moreover, in a series of M/A congeners, the correlation between in vitro PDEase III IC/sub 50/'s and in vivo inotropic ED/sub 50/'s was highly significant (r = 0.98, p < 0.01). In the crystal-state, the methyl substituent of M induces a marked alteration in its 3-dimensional topology relative to A. They have now completely assigned the /sup 13/C- and /sup 1/H-NMR spectra of A and M and have used the chemical shifts of the pyridone C-4 protons as conformational reporters. These studies revealed that the C-4 protons of methyl containing congeners (M-like) experience a 0.38-0.53 ppm upfield shift relative to the corresponding proton resonance in unmethylated congeners (A-like). These data suggest there are marked, methyl-induced differences in the solution conformations of A and M.
Research Organization:
Lilly Research Labs., Indianapolis, IN
OSTI ID:
6991704
Report Number(s):
CONF-8604222-
Conference Information:
Journal Name: Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States) Journal Volume: 45:4
Country of Publication:
United States
Language:
English